Herein, we report the structure-based selection via molecular docking of four -heterocyclic bis-carbene gold(I) complexes, whose potential as ligands for the hTel23 G-quadruplex structure has been investigated using circular dichroism (CD) spectroscopy, CD melting, and polyacrylamide gel electrophoresis (PAGE). The complex containing a bis(1,2,3,4,6,7,8,9-octahydro-11-11-pyridazino[1,2-a]indazol-11-yl) scaffold induces a transition from the hybrid (3 + 1) topology to a prevalent parallel G-quadruplex conformation, whereas the complex featuring a bis(2-(2-acetamidoethyl)-3-imidazo[1,5-a]pyridin-3(2)-yl) moiety disrupted the original G-quadruplex structure. These results deserve particular attention in light of the recent findings on the pathological involvements of G-quadruplexes in neurodegenerative diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11597854PMC
http://dx.doi.org/10.3390/molecules29225446DOI Listing

Publication Analysis

Top Keywords

structure-based selection
8
-heterocyclic bis-carbene
8
bis-carbene goldi
8
goldi complexes
8
complexes potential
8
potential ligands
8
g-quadruplex structure
8
study structure-based
4
selection -heterocyclic
4
ligands g-quadruplex-forming
4

Similar Publications

Gallic Acid: A Potent Metabolite Targeting Shikimate Kinase in .

Metabolites

December 2024

Pharmacognosy and Pharmaceutical Chemistry Department, Faculty of Pharmacy, Taibah University, Al Madinah Al Munawarah 30001, Saudi Arabia.

is a highly multidrug-resistant pathogen resistant to almost all classes of antibiotics; new therapeutic strategies against this infectious agent are urgently needed. Shikimate kinase is an enzyme belonging to the shikimate pathway and has become a potential target for drug development. This work describes the search for Food and Drug Administration (FDA)-approved drugs and natural compounds, including gallic acid, that could be repurposed as selective shikimate kinase inhibitors by integrated computational and experimental approaches.

View Article and Find Full Text PDF

Internal structure of the Patient Health Questionnaire-9: A systematic review and meta-analysis.

Asian Nurs Res (Korean Soc Nurs Sci)

December 2024

Graduate School of Public Health, Ajou University, Suwon, Republic of Korea. Electronic address:

Purpose: This review aimed to evaluate the internal structure (structural validity, internal consistency, and measurement invariance) of the Patient Health Questionnire-9 (PHQ-9), which is one of the most widely used self-administered instruments for assessing and screening depression.

Methods: The updated COnsensus-based Standards for the selection of health Measurement Instruments (COSMIN) methodology for a systematic review of self-reported instruments was used. PubMed, Embase, CINAHL, PsycINFO, and Cochrane Library databases were searched from their inception up to February 28, 2023.

View Article and Find Full Text PDF

FDA-approved drugs as PIM-1 kinase inhibitors: A drug repurposed approach for cancer therapy.

Int J Biol Macromol

December 2024

Department of Biotechnology, Faculty of Life Sciences, Jamia Millia Islamia, New Delhi 110025, India. Electronic address:

PIM-1 kinase, a member of the Serine/Threonine kinase family, has emerged as a promising therapeutic target in various cancers due to its role in promoting tumor growth and resistance to conventional therapies. In this study, we employed a structure-based approach to screen 3800 FDA-approved drugs to discover potential inhibitors of PIM-1. After an initial selection of 50 candidates based on high docking scores, four drugs, stanozolol, alfaxalone, rifaximin, and telmisartan, were identified as strong PIM-1 binders, interacting with key residues in the ATP-binding pocket of the kinase.

View Article and Find Full Text PDF

Introduction: Rates of prenatal cannabis use (PCU) have increased in recent years. Despite evidence of developmental health consequences to offspring and birthing person, there has been a reduction in the perception of PCU-related harms. Due to the stigma and risk of legal consequences associated with disclosing PCU, individuals are often cautious to seek information from their healthcare providers.

View Article and Find Full Text PDF

Structure-Based QSAR Modeling of RET Kinase Inhibitors from 49 Different 5,6-Fused Bicyclic Heteroaromatic Cores to Patent-Driven Validation.

ACS Omega

December 2024

College of Pharmacy, Gachon University, Medical Campus, Pharmacy, Hambakmoero 191, Yeonsu-gu, Incheon City 21936, Republic of Korea.

RET receptor tyrosine kinase is crucial for nerve and tissue development but can be an important oncogenic driver. This study focuses on exploring the design principles of potent RET inhibitors through molecular docking and 3D-QSAR modeling of 5,6-fused bicyclic heteroaromatic derivatives. First of all, RET inhibitors of 49 different bicyclic substructures were collected from five different data sources and selected through molecular docking simulations.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!